Rockwell Medical, Inc. · NASDAQ:RMTI
Rockwell Medical — Investor Presentation (August 2026)
16 slides from Rockwell Medical's investor presentation, Aug 13, 2026
Slide 1: Investor Presentation
MEDICAL Investor Presentation August 13, 2026 RMTI Nasdaq
Slide 2: Forward-Looking Statements
Forward-Looking Statements Certain statements in this presentation may constitute “forward-looking statements" within the meaning of federal securities laws, including, but not limited to, Rockwell's expectations regarding revenue, profitability, financial position, 2024, 2025 and 2026 guidance, fut
Slide 3: Rockwell Medical At A Glance
Rockwell Medical At A Glance Healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers worldwide Business Leading supplier of liquid bicarbonate hemodialysis concentrates in the U.S. Overview One of the largest supplie
Slide 4: Executive Management Team
Executive Management Team Mark Strobeck, PhD President and CEO Jesse Neri Chief Financial Officer ARUVANT beto<l al Symphony Health Zylam Heather Hunter Chief Operating Officer (@PCAREY) S SAFEGUARD Venatorx ©2026 Rockwell Medical, Inc. Tim Chole Chief Commercial Officer Baxter Watson Phar GAMBRO. M
Slide 5: Leading Manufacturer and Supplier of Hemodialysis Concentrates
Leading Manufacturer and Supplier of Hemodialysis Concentrates Hemodialysis is a Necessity for End Stage Kidney Disease Patients Approximately 490,000 patients in the U.S. require in-center hemodialysis annually’). Each patient receives approximately three treatments per week, totaling approximately
Slide 6: « RMTI © ROCKWELL
2024 SOURCE: CAGR based on "Rockwell Medical: Concentrates Growth Strategy Report”, L.E.K. Consulting LLC (2022) « RMTI ©2026 Rockwell Medical, Inc. © ROCKWELL Nasdaq Listed MEDICAL
Slide 7: Rockwell Currently Serves ~300 Customers throughout the U.S.
Rockwell Currently Serves ~300 Customers throughout the U.S. including Top Five Leading Dialysis Providers Dialysis Providers Hospital Systems i CA UPM HCA: Renal Care CONCERTO) C RSS i SANF2RD BaylorScotteWhite EAL HEALTH Greenfield Health Systems MAYO CLINIC Dedicated to Dialysis ay * LP FRESENIUS
Slide 8: Rockwell Distributes to 30+ Countries Worldwide
Rockwell Distributes to 30+ Countries Worldwide || Current Geographic Footprint | | Current Expansion Opportunities ©2026 Rockwell Medical, Inc. OQ ROCKWELL
Slide 9: Financials and Milestones
(ROCKWELL MEDICAL Financials and Milestones
Slide 10: Second Quarter 2026 Financial Results
Second Quarter 2026 Financial Results Three Months Ended Six Months Ended June 30 June 30 (in millions, Except Per Share Amounts) Net Sales Gross Profit Gross Margin Operating Income (Loss) (1.1) (1.2) (1.3) Net Income (Loss) (1.5) Basic and Diluted Net Income (Loss) per Share” (0.34) (0.04) (0.48)
Slide 11: On Track to Achieve Record Gross Margin in 2026
On Track to Achieve Record Gross Margin in 2026 mmm Adjusted EBITDA = —==Gross Margin a RMTI ©2026 Rockwell Medical, inc. OQ ROCKWELL Nasdaq
Slide 12: RMTI
12 RMTI Nasdaq Lis Maintain pi > ass servir ters in worldwide * Reliable supply * Consistent quality * Strong customer service * Sustainable margin performance ¢ Shareholder return Build a broa Integrate into our existing commercial, manufacturing and distribution infrastructure * Target products th
Slide 13: Long-Term Financial Framework Through 2029
Long-Term Financial Framework Through 2029 ~— Ce] Net Sales Profitability Gross Margin $100+ Million $5 Million to $10 million +30% Rockwell Medical believes the Company has a pathway to meaningfully grow its business and generate annual net sales of more than $100 million. Ongoing portfolio diversi
Slide 14: Why Invest in Rockwell Medical
Why Invest in Rockwell M Large, Recurring Market Opportunity Profitable, Revenue-Generating Business Projects to be Cash Flow Positive from Operations in 2026 and beyond Pursuing Investments in High-Growth Renal Care Opportunities No Additional Fundraising Required to Achieve Sustained Profitability
Slide 15: Nasdaq Listed
Nasdaq Listed www.rockwellmed.com Certified Fes 2eas-ree 2028 IR@rockwellmed.com usa
Slide 16: Reconciliation to GAAP Financial Measures
Reconciliation to GAAP Financial Measures Non-GAAP Financial Measures To supplement the Company's financial results presented on a U.S. generally accepted accounting principles ("GAAP") basis, the Company has Included information about non-GAAP measures of EBITDA and adjusted EBITDA as useful operat
Rockwell Medical — Investor Presentation (August 2026) on 6ix